UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 16, 2022
Accession Number:
0001493152-22-006504
Submission Type:
POS AM
CIK:
0001610820
Company Name:
BriaCell Therapeutics Corp.
File Number:
333-257104